QA: Dynavax Technologies CORP in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2017_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 89,599,000
1 IntangibleAssetsNetIncludingGoodwill 1,971,000
2 PropertyPlantAndEquipmentNet 17,174,000
3 remainder_Assets 936,000
4 LiabilitiesCurrent 20,036,000
5 LiabilitiesNoncurrent 443,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 47,515,118
9 ResearchAndDevelopmentExpense 84,482,220
10 remainder_Expenses -53,725
11 remainder_Revenues 8,679,746
12 remainder_NetIncome -1,625,100
13 remainder_ComprehensiveNetIncome -746,027
  yvar yval
0 Assets 109,680,000
1 Liabilities 20,479,000
2 Expenses 131,943,613
3 Revenues 8,679,746
4 StockholdersEquity 89,201,000
5 NetIncome -124,888,967
6 ComprehensiveNetIncome -125,261,980
7 BaseVar 136,576,743
8 EconomicCapitalRatiobeforeLimitedLiability 1.06
9 EconomicCapitalRatio 2.35

Edgar->Model Mapping

Feature Distribution

Change over Time